RA0423

antibody from Oursmab

Targeting: ITGA2B CD41, CD41B, GP2B, PPP1R93

ELISA (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0423

Provider

Oursmab

Product name

Tadocizumab (Biosimilar Reference Antibody) (ITGA2B and ITGB3)

Antibody type

Monoclonal

Description

Tadocizumab is a humanized monoclonal antibody targeting integrin ¦Áv¦Â3, a cell adhesion receptor involved in angiogenesis, tumor metastasis, and bone resorption. It binds to ¦Áv¦Â3 to inhibit its interaction with extracellular matrix proteins (e.g., vitronectin), thereby suppressing tumor growth, osteoclast activity, and pathological vascularization. It is being developed for the treatment of solid tumors, osteoporosis, and neovascular eye diseases.

Reactivity

Human

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.